These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28551384)

  • 1. CPEB4 immunohistochemical expression is associated to prognosis in stage IV colorectal carcinoma.
    Cortés-Guiral D; Pastor-Iodate C; Díaz Del Arco C; Del Puerto-Nevado L; Fernández-Aceñero MJ
    Pathol Res Pract; 2017 Jun; 213(6):639-642. PubMed ID: 28551384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological aspects of the hepatic response to neoadjuvant therapy.
    Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
    Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of cytoplasmic polyadenylation element-binding protein 4 correlates with poor prognosis of patients with colorectal cancer.
    He X; Lin X; Cai M; Fan D; Chen X; Wang L; Wu X; Lan P; Wang J
    Virchows Arch; 2017 Jan; 470(1):37-45. PubMed ID: 27771769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma.
    Fernández-Aceñero MJ; Cortés D; Gómez del Pulgar T; Cebrián A; Estrada L; Martínez-Useros J; Celdrán A; García-Foncillas J; Pastor C
    Pathol Oncol Res; 2016 Apr; 22(2):377-83. PubMed ID: 26577686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
    Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.
    Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
    Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.
    Nakazawa T; Goi T; Hirono Y; Yamaguchi A
    Ann Surg Oncol; 2015 May; 22(5):1496-503. PubMed ID: 25331005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
    Wang L; Lin D; Fu Y; Lai M
    Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CPEB4 in invasive ductal breast carcinoma and its prognostic significance.
    Sun HT; Wen X; Han T; Liu ZH; Li SB; Wang JG; Liu XP
    Onco Targets Ther; 2015; 8():3499-506. PubMed ID: 26648741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer.
    Gonen M; Hummer A; Zervoudakis A; Sullivan D; Fong Y; Banerjee D; Klimstra D; Cordon-Cardo C; Bertino J; Kemeny N
    J Clin Oncol; 2003 Feb; 21(3):406-12. PubMed ID: 12560427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.
    Dobi E; Monnien F; Kim S; Ivanaj A; N'Guyen T; Demarchi M; Adotevi O; Thierry-Vuillemin A; Jary M; Kantelip B; Pivot X; Godet Y; Degano SV; Borg C
    Clin Colorectal Cancer; 2013 Mar; 12(1):28-36. PubMed ID: 23083634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High pKDR immunohistochemical expression is an unfavourable prognostic biomarker in patients with advanced colorectal cancer treated with chemotherapy plus bevacizumab.
    Garde-Noguera J; Gil-Raga M; Evgenyeva E; García JA; Llombart-Cussac A; Camps-Herrero C
    Clin Transl Oncol; 2016 Apr; 18(4):405-12. PubMed ID: 26307753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of osteoprotegerin expression in metastatic colorectal carcinoma predicts recurrent metastasis and poor prognosis.
    Moon A; Do SI; Kim HS; Kim YW
    Oncotarget; 2016 Nov; 7(48):79319-79326. PubMed ID: 27764814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.
    Zong Z; Zhou T; Rao L; Jiang Z; Li Y; Hou Z; Yang B; Han F; Chen S
    Cancer Med; 2016 Apr; 5(4):623-30. PubMed ID: 26775684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
    Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
    Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.
    Wang HX; Qin R; Mao J; Huang QL; Hong F; Li F; Gong ZY; Xu T; Yan Y; Chao SH; Zhang SK; Chen JX
    Clin Neurol Neurosurg; 2018 Jun; 169():92-97. PubMed ID: 29642043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic and Stage-Associated Expression of CPEB4 in Hepatocellular Carcinoma.
    Tsai LY; Chang YW; Lee MC; Chang YC; Hwang PI; Huang YS; Cheng CF
    PLoS One; 2016; 11(5):e0155025. PubMed ID: 27158894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.